Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuwen Liu

Showing results (21-30 of 460) with videos related to

Pageof 46
Sort By:
Expert Opinion on Emerging Drugs|November 17, 2022
Emerging antiviral therapies and drugs for the treatment of influenzaJinshen Wang, Yihang Sun, Shuwen Liu
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 9, 2010
HIV-1 gp41 fusion intermediate: a target for HIV therapeuticsChungen Pan, Shuwen Liu, Shibo Jiang
The Lancet. Infectious Diseases|October 28, 2006
China needs safe and effective microbicides for preventing sexual transmission of HIVShibo Jiang, Shuwen Liu, Alan Stone
Current Pharmaceutical Design|February 3, 2007
HIV entry inhibitors targeting gp41: from polypeptides to small-molecule compoundsShuwen Liu, Shuguang Wu, Shibo Jiang
Peptides|January 7, 2004
Determination of the HIV-1 gp41 fusogenic core conformation modeled by synthetic peptides: applicable for identification of HIV-1 fusion inhibitorsShuwen Liu, Qian Zhao, Shibo Jiang
Journal of Thoracic Disease|August 27, 2013
Novel hemagglutinin-based influenza virus inhibitorsXintian Shen, Xuanxuan Zhang, Shuwen Liu
Journal of Molecular Modeling|November 21, 2013
Theoretical studies of the interaction between influenza virus hemagglutinin and its small molecule ligandsDeshou Song, Hanhong Xu, Shuwen Liu
American Journal of Translational Research|January 17, 2025
Comprehensive treatment focusing on transarterial chemoembolization for postoperative liver metastasis in gastric cancer patientsXingdong Wang, Bin Fan, Shuwen Liu
Expert Opinion on Investigational Drugs|December 6, 2016
Investigational hemagglutinin-targeted influenza virus inhibitorsLi-Yan Zeng, Jie Yang, Shuwen Liu
Protein & Cell|January 5, 2011
Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccinesShibo Jiang, Runming Li, Lanying Du, et al.
Pageof 46

Showing results (21-30 of 460) with videos related to

Sort By:
Pageof 46
Expert Opinion on Emerging Drugs|November 17, 2022
Emerging antiviral therapies and drugs for the treatment of influenzaJinshen Wang, Yihang Sun, Shuwen Liu
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 9, 2010
HIV-1 gp41 fusion intermediate: a target for HIV therapeuticsChungen Pan, Shuwen Liu, Shibo Jiang
The Lancet. Infectious Diseases|October 28, 2006
China needs safe and effective microbicides for preventing sexual transmission of HIVShibo Jiang, Shuwen Liu, Alan Stone
Current Pharmaceutical Design|February 3, 2007
HIV entry inhibitors targeting gp41: from polypeptides to small-molecule compoundsShuwen Liu, Shuguang Wu, Shibo Jiang
Peptides|January 7, 2004
Determination of the HIV-1 gp41 fusogenic core conformation modeled by synthetic peptides: applicable for identification of HIV-1 fusion inhibitorsShuwen Liu, Qian Zhao, Shibo Jiang
Journal of Thoracic Disease|August 27, 2013
Novel hemagglutinin-based influenza virus inhibitorsXintian Shen, Xuanxuan Zhang, Shuwen Liu
Journal of Molecular Modeling|November 21, 2013
Theoretical studies of the interaction between influenza virus hemagglutinin and its small molecule ligandsDeshou Song, Hanhong Xu, Shuwen Liu
American Journal of Translational Research|January 17, 2025
Comprehensive treatment focusing on transarterial chemoembolization for postoperative liver metastasis in gastric cancer patientsXingdong Wang, Bin Fan, Shuwen Liu
Expert Opinion on Investigational Drugs|December 6, 2016
Investigational hemagglutinin-targeted influenza virus inhibitorsLi-Yan Zeng, Jie Yang, Shuwen Liu
Protein & Cell|January 5, 2011
Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccinesShibo Jiang, Runming Li, Lanying Du, et al.
Pageof 46